abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página no está disponible en Español y está siendo mostrada en English

Artículo

30 Nov 2006

Autor:
Interfaith Center on Corporate Responsibility [USA]

[PDF] Benchmarking AIDS: 2006 Year End Update

Pharmaceutical companies continue to fall short on providing access to essential medicines... However, investors found that some companies have taken steps towards improving public health in poor countries and protecting long-term shareholder value... [Includes recent steps by Abbott, Gilead, GlaxoSmithKline, Novartis, and Roche and recommendations for next steps for each of these companies.]

Línea del tiempo